Neuro Event Labs

Country:
Finland
Founding year:
2015

Neuro Event Labs develops Nelli, an AI-powered seizure monitoring system for epilepsy diagnostics, follow-up, and clinical workflow support. The platform is designed to give clinicians objective seizure-event data in hospitals, epilepsy centers, and clinical research settings where event characterization can be difficult to capture reliably.

Nelli uses video and audio recordings from a dedicated monitoring unit, then applies machine-learning algorithms to detect events indicative of motor seizures. Clinicians can review prioritized events, media clips, and structured reports through a web-based dashboard, supporting diagnostic review and longitudinal monitoring.

The system has received FDA 510(k) clearance for adult seizure monitoring in healthcare facilities and has also been used commercially in European clinical settings. Neuro Event Labs is best understood as a regulated clinical monitoring company focused on making seizure observation and documentation more scalable within epilepsy care.

Tools and Infrastructure
Diagnostics
Monitoring

Neurofounders Insights

Modality:
Biomarkers
Form Factor:
Software/app
Interface Depth:
Non-invasive
Indication:
Epilepsy
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Series A

Neuro Event Labs sits in the clinical seizure-monitoring infrastructure segment, using AI analysis of video and audio to support epilepsy diagnostics and follow-up. Its positioning is differentiated by focusing on objective seizure-event capture within clinical workflows, especially where continuous specialist observation is difficult to scale.

Related companies

Articles featuring

Neuro Event Labs

No articles yet!

Press releases

No press releases published yet.